Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Change in Accured Expenses (2016 - 2026)

Ekso Bionics Holdings has reported Change in Accured Expenses over the past 14 years, most recently at -$348000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 237.55% to -$348000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 million, a 83.97% decrease, with the full-year FY2025 number at -$1.1 million, down 83.97% from a year prior.
  • Change in Accured Expenses reached -$348000.0 in Q4 2025 per EKSO's latest filing, down from -$38000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $568000.0 in Q3 2022, with the low at -$723000.0 in Q1 2024.
  • The 5-year median for Change in Accured Expenses is -$104500.0 (2024), against an average of -$82650.0.
  • Peak YoY movement for Change in Accured Expenses: plummeted 3250.0% in 2022, then soared 431.51% in 2023.
  • Tracing EKSO's Change in Accured Expenses over 5 years: stood at $449000.0 in 2021, then crashed by 83.74% to $73000.0 in 2022, then soared by 431.51% to $388000.0 in 2023, then tumbled by 34.79% to $253000.0 in 2024, then tumbled by 237.55% to -$348000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$348000.0, -$38000.0, and -$518000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.